Ebola drug trial starts in Liberia

Liberia will receive an untested experimental drug, Zmapp, to treat people infected with Ebola, the government says following a request to the US.

The first large-scale trials of an experimental vaccine against the deadly Ebola virus are due to begin in Liberia.

Full trial of the Sh5.2 billion drug-haul case commenced yesterday without two key Pakistani suspects who have an arrest warrant on their heads.

The trial of four men charged over the deadly Westgate shopping centre siege in Kenya starts in the capital, Nairobi.

New GDP Estimates Show International Support Vital to Speed Recovery

The World Bank Group (WBG) announced today that it would provide at least US$650 million during the next 12 to 18 months to help Guinea, Liberia and Sierra Leone recover from the devastating social and economic impact of the Ebola crisis and advance their longer-term development needs. The new WBG pledge brings the organization’s total financing for Ebola response and recovery efforts to date to US$1.62 billion.

The...

Pharmaceutical firm to donate two million tablets of malaria drug to world's largest COVID-19 trial  Daily MailScientists search for effective COVID-19 treatments  Al Jazeera EnglishWhat do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life.  USA TODAYCoronavirus: Clinical trial of hydroxychloroquine for COVID-19 treatment begins in US  Gulf NewsTrump’s chloroquine hype is a misinformation problem bigger than social media  The VergeView Full coverage on Google...

US aid workers who contracted the deadly Ebola virus in Liberia appear to be improving after receiving an experimental drug, officials says.

The British volunteer nurse William Pooley, who contracted Ebola while working in Sierra Leone, has been given the experimental drug ZMapp.

The World Health Organisation has declared Liberia free of Ebola, after the country reached the milestone of no new cases in 42 days.